Penumbra Inc (PEN) Stock Analysis

Penumbra Inc (PEN) is a publicly traded company in the HEALTHCARE sector. It trades at $318.84, carries a market capitalization of $12.54B, a price-to-earnings ratio of 73.66. This page summarizes the public market data, fundamentals, and frequently asked questions for PEN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

• Price: $318.84
• Market Cap: $12.54B
• P/E Ratio: 73.66
• EPS: $4.33
• 52-Week High: $362.41
• 52-Week Low: $221.26

Market Sentiment

Penumbra Inc currently has a Bearish sentiment score of -0.15.

About Penumbra Inc

Penumbra, Inc. is a biotechnology-driven medical device company focused on transforming the treatment landscape for neurological and vascular conditions. Based in Alameda, California, Penumbra employs a global reach with operations across major markets, including the United States, Europe, Canada, and Australia. The company's dedication to innovation and quality underpins its portfolio of advanced therapeutic solutions, aimed at improving patient outcomes and enhancing clinician workflows, th...

GNG Research Analysis

GNG Research scores Penumbra Inc (PEN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PEN.

Frequently Asked Questions

Does PEN pay dividends?

Penumbra Inc (PEN) does not currently pay a regular dividend.

What is PEN's P/E ratio?

Penumbra Inc has a price-to-earnings (P/E) ratio of 73.66.

What is PEN's market cap?

Penumbra Inc (PEN) has a market capitalization of $12.54B with a current stock price of $318.84.